Gene Therapy in Ophthalmology: Validation on Cultured Retinal Cells and Explants from Postmortem Human Eyes
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Gene therapy studies in primates can provide important information regarding vector tropism, specific cellular expression, biodistribution, and safety prior to clinical trials. In this study, we report the assessment of transduction efficiency of recombinant adeno-associated virus (rAAV) vectors using human postmortem retina. Transductions were performed using two in vitro models prepared from human tissue: dissociated cell cultures and retinal explants. These models were used to assess cellular tropism and selectivity of rAAV vectors encoding for fluorescent proteins under the control of different promoters. These promoters were a ubiquitous cytomegalovirus promoter and a cell type–specific promoter targeting expression in ON bipolar cells. The results demonstrate that this in vitro approach can limit the use of living primates for the validation of gene therapy in vision and ophthalmology. Fradot and colleagues propose a new ex vivo approach for the preclinical assessment of gene transfer efficacy in the retina. The authors use human postmortem retinas to generate two in vitro models prepared from human tissue: dissociated cell cultures and retinal explants. These models were used to assess cellular tropism and selectivity of rAAV vectors encoding fluorescent proteins under the control of different promoters. The authors claim that this work paves the way for the wider use of postmortem human retina in other studies, even if these models cannot fully replace in vivo testing in primates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145 · cited 1×
“Recent clinical trials have validated gene therapy for the treatment of an inherited blinding disease previously considered incurable (Bainbridge and Ali, 2008; Cideciyan et al., 2008; Maguire et al., 2008).”
Self-citationEffect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924 · cited 2×
“First clinical evaluations indicate a gain of visual performance and an absence of side effects, supporting the safety and efficiency of recombinant adeno-associated virus (rAAV) vectors for retinal disease treatment (Bainbridge et al., 2008; Hauswirth et al., 2008; Maguire et al., 2008, 2009; Cideciyan et al., 2009).”
Gene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202 · cited 1×
“Efficacy was demonstrated in transgenic and natural murine models for LCA2 (Dejneka et al ., 2004; Lai et al ., 2004; Pang et al ., 2006), as well as in a natural occurring canine model of the disease, the Briard dog (Acland et al ., 2001; Le Meur et al ., 2007).”
Self-citationHauswirth, W. W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T. J., Boye, S. L., Flotte, T. R., Byrne, B. J., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.107 · Cited by 954 · cited 1×
“…indicate a gain of visual performance and an absence of side effects, supporting the safety and efficiency of recombinant adeno-associated virus (rAAV) vectors for retinal disease treatment (Bainbridge et al ., 2008; Hauswirth et al ., 2008; Maguire et al ., 2008, 2009; Cide-ciyan et al ., 2009).”
Maguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61836-5 · Cited by 865 · cited 1×
“…indicate a gain of visual performance and an absence of side effects, supporting the safety and efficiency of recombinant adeno-associated virus (rAAV) vectors for retinal disease treatment (Bainbridge et al ., 2008; Hauswirth et al ., 2008; Maguire et al ., 2008, 2009; Cide-ciyan et al ., 2009).”
Self-citation
Cited by
Early and late stage gene therapy interventions for inherited retinal degenerations
Botto, C., Rucli, M., Tekinsoy, M. D., Pulman, J., Sahel, J.-A., & Dalkara, D. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100975 · Cited by 190
Self-citationRoska, B., & Sahel, J.-A. (2018) · Nature · doi:10.1038/s41586-018-0076-4 · Cited by 161
Self-citationNovel adeno-associated viral vectors for retinal gene therapy.
Vandenberghe, L. H., & Auricchio, A. (2012) · Gene Therapy · doi:10.1038/gt.2011.151 · Cited by 131
Noninvasive gene delivery to foveal cones for vision restoration
Khabou, H., Garita-Hernandez, M., Chaffiol, A., Reichman, S., Jaillard, C., Brazhnikova, E., Bertin, S., Forster, V., Desrosiers, M., Winckler, C., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.96029 · Cited by 124
Self-citationOptogenetic Light Sensors in Human Retinal Organoids
Garita-Hernandez, M., Guibbal, L., Toualbi, L., Routet, F., Chaffiol, A., Winckler, C., Harinquet, M., Robert, C., Fouquet, S., Bellow, S., et al. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00789 · Cited by 65
Self-citation
Metadata
- Authors
- Fradot, M., Busskamp, V., Forster, V., Cronin, T., Léveillard, T., Bennett, J., Sahel, J.-A., Roska, B., & Picaud, S.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2011-05
- Volume
- 22
- Issue
- 5
- Pages
- 587-593
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2016197640
- Cited by
- 51
- References
- 5
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gene Therapy in Ophthalmology: Validation on Cultured Retinal Cells and Explants from Postmortem Human Eyes. https://app.cochat.ai/papers/10.1089/hum.2010.157
- The paper
- Fradot, M., Busskamp, V., Forster, V., Cronin, T., Léveillard, T., Bennett, J., Sahel, J.-A., Roska, B., & Picaud, S. (2011). Gene Therapy in Ophthalmology: Validation on Cultured Retinal Cells and Explants from Postmortem Human Eyes. Human Gene Therapy. https://doi.org/10.1089/hum.2010.157
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.